CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16INK4A

Journal of Cellular Biochemistry

Volumn 114, Issue 6, 2013, Pages 1343-1354

  Guan, Chengqi ^a   Shi, Hui ^a   Wang, Huijie ^b   Zhang, Jianguo ^a   Ni, Wenkai ^a   Chen, Buyou ^a   Hou, Sicong ^a   Yang, Xiaojing ^a   Shen, Aiguo ^c   Ni, Runzhou ^a  

^a NANTONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c NANTONG MEDICAL COLLEGE   (China)

Author keywords

C Terminal Binding Protein 2 (CtBP2); Esophageal Squamous Cell Carcinoma (ESCC); Malignant Development; p16INK4A

Indexed keywords

BINDING PROTEIN; C TERMINAL BINDING PROTEIN 2; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; KI 67 ANTIGEN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL COUNT; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL OXIDOREDUCTASES; ANTINEOPLASTIC AGENTS; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PROGNOSIS;

EID: 84876273354     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24475     Document Type: Article

References (43)

1. Al-Mohanna MA, Manogaran PS, Al-Mukhalafi Z, Al-Hussein KA, Aboussekhra A,. 2004. The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin. Oncogene 23: 201-212.
2. Bergman LM, Blaydes JP,. 2006. C-terminal binding proteins: Emerging roles in cell survival and tumorigenesis. Apoptosis 11: 879-888.
3. Bergman LM, Morris L, Darley M, Mirnezami AH, Gunatilake SC, Blaydes JP,. 2006. Role of the unique N-terminal domain of CtBP2 in determining the subcellular localisation of CtBP family proteins. BMC Cell Biol 7: 35.
4. Bergman LM, Birts CN, Darley M, Gabrielli B, Blaydes JP,. 2009. CtBPs promote cell survival through the maintenance of mitotic fidelity. Mol Cell Biol 29: 4539-4551.
5. Boyd JM, Subramanian T, Schaeper U, La Regina M, Bayley S, Chinnadurai G,. 1993. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J 12: 469-478.
6. Chen YW, Paliwal S, Draheim K, Grossman SR, Lewis BC,. 2008. p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein. Cancer Res 68: 476-482.
7. Cheng TH, Hsu PK, Li AF, Hung IC, Huang MH, Hsu HS,. 2009. Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 135: 1577-1582.
8. Chinnadurai G,. 2002. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell 9: 213-224.
9. Chinnadurai G,. 2009. The transcriptional corepressor CtBP: A foe of multiple tumor suppressors. Cancer Res 69: 731-734.
10. Enzinger PC, Mayer RJ,. 2003. Esophageal cancer. N Engl J Med 349: 2241-2252.
11. Fang K, Chiu CC, Li CH, Chang YT, Hwang HT,. 2007. Cisplatin-induced senescence and growth inhibition in human non-small cell lung cancer cells with ectopic transfer of p16INK4a. Oncol Res 16: 479-488.
12. Fujiwara S, Noguchi T, Takeno S, Kimura Y, Fumoto S, Kawahara K,. 2008. Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas. Dis Esophagus 21: 125-131.
13. Grooteclaes ML, Frisch SM,. 2000. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19: 3823-3828.
14. Grooteclaes M, Deveraux Q, Hildebrand J, Zhang Q, Goodman RH, Frisch SM,. 2003. C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc Natl Acad Sci U S A 100: 4568-4573.
15. Gutierrez C, Ramirez-Parra E, Castellano MM, del Pozo JC,. 2002. G(1) to S transition: more than a cell cycle engine switch. Curr Opin Plant Biol 5 (6): 480-486.
16. Hanahan D, Weinberg RA,. 2000. The hallmarks of cancer. Cell 100: 57-70.
17. Hildebrand JD, Soriano P,. 2002. Overlapping and unique roles for C-terminal binding protein 1 (CtBP1) and CtBP2 during mouse development. Mol Cell Biol 22: 5296-5307.
18. Hirama T, Koeffler HP,. 1995. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86: 841-854.
19. Johnstone RW, Ruefli AA, Lowe SW,. 2002. Apoptosis: A link between cancer genetics and chemotherapy. Cell 108 (2): 153-164.
20. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE, Skolnick MH,. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
21. Kataoka M, Wiehle S, Spitz F, Schumacher G, Roth JA, Cristiano RJ,. 2000. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells. Oncogene 19: 1589-1595.
22. Katsuda K, Kataoka M, Uno F, Murakami T, Kondo T, Roth JA, Tanaka N, Fujiwara T,. 2002. Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells. Oncogene 21: 2108-2113.
23. Li K,. 2002. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90. Int J Cancer 102 (3): 271-274.
24. Mroz EA, Baird AH, Michaud WA, Rocco JW,. 2008. COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells. Cancer Res 68: 6049-6053.
25. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA,. 1994. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756.
26. Ortega S, Malumbres M, Barbacid M,. 2002. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602: 73-87.
27. Paliwal S, Pande S, Kovi RC, Sharpless NE, Bardeesy N, Grossman SR,. 2006. Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis. Mol Cell Biol 26: 2360-2372.
28. Paliwal S, Kovi RC, Nath B, Chen YW, Lewis BC, Grossman SR,. 2007. The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor. Cancer Res 67: 9322-9329.
29. Ruas M, Peters G,. 1998. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1378: F115-F177.
30. Sandig V, Brand K, Herwig S, Lukas J, Bartek J, Strauss M,. 1997. Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat Med 3: 313-319.
31. Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G,. 1995. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A. 92: 10467-10471.
32. Serrano M, Hannon GJ, Beach D,. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
33. Sherr CJ,. 2004. Principles of tumor suppression. Cell 116: 235-246.
34. Sherr CJ, Roberts JM,. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
35. Sollerbrant K, Chinnadurai G, Svensson C,. 1996. The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation. Nucleic Acids Res 24: 2578-2584.
36. Subramanian T, La Regina M, Chinnadurai G,. 1989. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein. Oncogene 4: 415-420.
37. Thio SSC, Bonventre JV, Stephen I, Hsu H,. 2004. The CtBP2 co-repressor is regulated by NADH-dependent dimerization and possesses a novel N-terminal repression domain. Nucleic Acids Res 32: 1836-1847.
38. Vermeulen K, Van Bockstaele DR, Berneman ZN,. 2003. The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36: 131-149.
39. Witkiewicz AK, Knudsen KE, Dicker AP, Knudsen ES,. 2011. The meaning of p16ink4a expression in tumors: Functional significance, clinical associations and future developments. Cell Cycle 10: 2497-2503.
40. Xiong Y, Zhang H, Beach D,. 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7 (8): 1572-1583.
41. Yip HT, Chopra R, Chakrabarti R, Veena MS, Ramamurthy B, Srivatsan ES, Wang MB,. 2006. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53. Arch Otolaryngol Head Neck Surg 132: 317-326.
42. Zhang Q, Nottke A, Goodman RH,. 2005. Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis. Proc Natl Acad Sci U S A 102: 2802-2807.
43. Zhao LJ, Subramanian T, Zhou Y, Chinnadurai G,. 2006. Acetylation by p300 regulates nuclear localization and function of the transcriptional corepressor CtBP2. J Biol Chem 281: 4183-4189.